Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;32(3):475-83.
doi: 10.1007/s00381-015-2983-0. Epub 2016 Jan 26.

A cross-sectional study of carnitine deficiency and fatigue in pediatric cancer patients

Affiliations

A cross-sectional study of carnitine deficiency and fatigue in pediatric cancer patients

Jin-Shei Lai et al. Childs Nerv Syst. 2016 Mar.

Abstract

Purpose: Carnitine deficiency has been found in cancer patients and has been associated with fatigue. This study aimed to explore the prevalence of carnitine deficiency in pediatric cancer patients and its relationship with fatigue and other potential contributing factors.

Methods: Children with cancer or Langerhans cell histiocytosis who were receiving treatment or had completed therapy were eligible. Patients completed the Pediatric Functional Assessment of Chronic Illness-Fatigue, the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale, a numeric fatigue rating, and had carnitine levels obtained. Carnitine deficiency was defined as a total and/or free carnitine level less than normal for age or an acylcarnitine value higher than normal for age.

Results: Data from 142 children aged 8-17 were analyzed. Twenty-eight of 142 (19.7 %) had decreased total and 42.8 % (12/28) had decreased free carnitine levels. No patients had elevated acylcarnitine levels or elevated ratios. Patients with versus without carnitine deficiency differed by age (p = 0.043), treatment (p = 0.037), duration since last chemotherapy (p = 0.020), and body mass index (p = 0.010), but not fatigue, when all data were analyzed together. Yet, a negative relationship between fatigue and carnitine levels was found on a subgroup (off-therapy; fatigue worse than the norm).

Conclusion: No significant association between fatigue and carnitine level was demonstrated when data from all patients were analyzed together; however, a significant yet unexpected relationship was found for patients who completed therapy and reported elevated fatigue. Given the small sample size, these results should be interpreted with caution. Future studies to explore impact upon excessive carnitine levels are warranted.

Keywords: Cancer; Carnitine; Children; Fatigue.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement The authors declare that no conflict of interest exists.

Figures

Fig. 1
Fig. 1
Scatter plots between carnitine value and fatigue scores. a pedsFACIT-Fatigue versus free carnitine. b MFS total versus free carnitine. c pedsFACIT-Fatigue versus total carnitine. d MFS total versus total carnitine

Similar articles

Cited by

References

    1. Henry D, Viswanathan HN, Elkin E, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer. 2008;16:791–801. - PubMed
    1. Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. Oncologist. 2007;12:4–10. - PubMed
    1. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst. 2008;100:1155–1166. - PubMed
    1. Morrow GR. Cancer-related fatigue: causes, consequences, and management. Oncologist. 2007;12:1–3. - PubMed
    1. Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist. 2007;12:22–34. - PubMed

Publication types

LinkOut - more resources